HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER		Author Keyword(s) Vol Page [Advanced]

This Article Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this link to a friend Similar articles in this journal Similar articles in PubMed Add article to my folders Download to citation manager Request Permissions Google Scholar Articles by Ross, H. Articles by Phu, V. X. PubMed PubMed Citation Articles by Ross, H. Articles by Phu, V. X.

The costs of smoking in Vietnam: the case of inpatient care

¹ American Cancer Society, Atlanta, GA, USA
² Hanoi School of Public Health, Hanoi, Vietnam

Correspondence to:
Hana Ross, PhD, Epidemiology and Surveillance Research, American Cancer Society, 250 Williams Street NW, Atlanta, GA 30303-1002, USA; hana.ross{at}cancer.org

Objective: To estimate the social costs of smoking related to inpatient care in Vietnam using 2005 data.

Design: The cost of illness as a result of hospitalisation for three major smoking-related diseases combined with the prevalence-based approach to obtain the costs of smoking in Vietnam for inpatient care.

Main outcome measure: Smoking-attributable costs of inpatient care for lung cancer, chronic obstructive pulmonary disease (COPD), and ischaemic heart disease.

Results: The total cost of inpatient health care caused by smoking in Vietnam reached at least 1 161 829 million Vietnamese dollars ($VN) (or $US77.5 million) in 2005. This represents about 0.22% of Vietnam gross domestic product (GDP) and 4.3% of total healthcare expenditure. The majority of these expenses are related to COPD treatment ($VN1 033 541 million or $US68.9 million per year) followed by lung cancer ($VN78 143 million, or $US5.2 million per year) and ischaemic disease ($VN50 145 million, or $US3.3 million per year). The government directly finances about 51% of these costs. The rest is financed either by households (34%) or by the insurance sector (15%).

Conclusions: The social costs of smoking in Vietnam as the percentage of GDP is lower compared to estimates from high-income countries. The true costs would be substantially higher if all smoking-related diseases, outpatient care and mortality-related costs are included. More research is needed to augment the estimates presented in this paper.

Abbreviations: COPD, chronic obstructive pulmonary disease; SAC, smoking-attributable inpatient costs; SAF, smoking-attributable fraction; SES, socioeconomic status

Keywords: Vietnam; smoking and health